Licensed Practical Nurse in Bartlesville, OK Accepting Medicare

7 Licensed Practical Nurse nurses found. Showing 1 - 7

Stephanie Rachelle Daniels, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 610 W Hensley Blvd, Bartlesville, OK 74003 Phone: 918-337-6007

Felecia Rhea Beisley, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 129 Se Avondale Ave, Bartlesville, OK 74006 Phone: 918-886-7102

Paul S Wallace, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 513 Se Quapaw, Bartlesville, OK 74003 Phone: 918-337-8080    Fax: 918-337-8099

Krista Hambright, LPN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 513 Se Quapaw, Bartlesville, OK 74003 Phone: 918-337-8080    Fax: 918-337-8099

Melissa Landrum, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 1655 Cherokee Pl, Bartlesville, OK 74003 Phone: 918-815-1515

Violet Marie Bryant, Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 610 W Hensley Blvd, Bartlesville, OK 74003 Phone: 918-337-6007

Kathleen Wolfe, RN Licensed Practical Nurse Medicare: Not Enrolled in Medicare Practice Location: 700 S Penn Ave, Washington County Clinic, Bartlesville, OK 74003 Phone: 918-337-8080    Fax: 918-337-8099

News Archive

Derma Sciences reports financial and operating results for 2013

Derma Sciences, Inc., a medical device and pharmaceutical company focused on advanced wound care, today reported financial and operating results for the three and six months ended June 30, 2013.

Genetic variation associated with increased risk of sudden cardiac arrest

A study by a global consortium of physician-scientists has identified a genetic variation that may predispose people to double the risk of having a sudden cardiac arrest, a disorder that gives little warning and is fatal in about 95 percent of cases.

FFTC and FDA act against internet vendors of fraudulent diabetes treatments

The Federal Trade Commission (FTC) and the Food and Drug Administration (FDA), working with government agencies in Mexico and Canada, have launched a drive to stop deceptive Internet advertisements and sales of products misrepresented as cures or treatments for diabetes.

Enrollment suspended in WorldHeart's Levacor Ventricular Assist Device Bridge-To-Transplant Study

World Heart Corporation, a developer of mechanical circulatory systems, announced today that it has paused enrollment in its Levacor Ventricular Assist Device (VAD) Bridge-To-Transplant (BTT) Study pending U.S. Food and Drug Administration (FDA) review and approval of the previously announced device refinements.

Read more Medical News

› Verified 6 days ago